Published :
Tables : 70
Figures : 50
Category : Healthcare
No. of Pages : 230
Report Code : HC-U3196
Influenza Vaccine Market is projected to value over USD 7 billion by 2027 end with a CAGR of over 6.2% during the forecast period 2020 to 2027. The rise in the number of initiatives undertaken by government authorities for creating awareness regarding influenza, advancements in the medications provided for influenza treatment thus minimizing the side effects associated with influenza are some of the factors accountable for the proliferation of the market. FutureWise Market Research has instantiated a report that provides an intricate analysis of Influenza Vaccine Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market. According to the research study conducted by FutureWise research analysts, the Influenza Vaccine Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical. Major players included in the Influenza Vaccine Market: ASTRAZENECA PLC (ASTRAZENECA) BIODIEM CSL LIMITED (SEQIRUS GMBH) EMERGENT BIOSOLUTIONS F. HOFFMANN-LA ROCHE LTD. GAMMA VACCINES PTY LTD. GLAXOSMITHKLINE PLC MERCK & CO., INC. (MERCK SHARP & DOHME CORP.) NOVARTIS AG PFIZER INC. SANOFI SINOVAC BIOTECH LTD. (Note: The list of the major players will be updated with the latest market scenario and trends) Influenza Vaccine Market Segmentation: By Vaccine Type Quadrivalent Trivalent By Type Seasonal Pandemic By Technology Egg-based Cell-based By Age Group Pediatric Adult By Route of Administration Injection Nasal Spray By Region North America Europe Asia-Pacific Latin America Middle East and Africa Competitive Landscape: Tier 1 players- established companies in the market with a major market share Tier 2 players Emerging players which are growing rapidly New Entrants FutureWise Key Takeaways: Growth prospects SWOT analysis Key trends Key data-points affecting market growth Objectives of the Study: To provide with an exhaustive analysis on the Influenza Vaccine Market By Vaccine Type, By Type, By Technology, By Age Group, By Route of Administration and By Region. To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) To evaluate and forecast micro-markets and the overall market To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement The customization Mobility Care offered are free of charge with purchase of any license of the report You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
The rise in the number of initiatives undertaken by government authorities for creating awareness regarding influenza, advancements in the medications provided for influenza treatment thus minimizing the side effects associated with influenza are some of the factors accountable for the proliferation of the market.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Influenza Vaccine Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Influenza Vaccine Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.
Major players included in the Influenza Vaccine Market:
(Note: The list of the major players will be updated with the latest market scenario and trends)
Influenza Vaccine Market Segmentation:
By Vaccine Type
By Type
By Technology
By Age Group
By Route of Administration
By Region
Competitive Landscape:
FutureWise Key Takeaways:
Objectives of the Study:
Flexible Delivery Model:
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders 2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data from Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data from Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study 3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights 4. Global Influenza Vaccine Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Influenza Vaccine Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Global Influenza Vaccine Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Global Influenza Vaccine Market, By Vaccine Type Historical Analysis and Forecast 2020-2027 (USD Million) 7.1. Quadrivalent 7.2. Trivalent 8. Global Influenza Vaccine Market, By Type Historical Analysis and Forecast 2020-2027 (USD Million) 8.1. Seasonal 8.2. Pandemic 9. Global Influenza Vaccine Market, By Technology Historical Analysis and Forecast 2020-2027 (USD Million) 9.1. Egg-based 9.2. Cell-based 10. Global Influenza Vaccine Market, By Age Group Historical Analysis and Forecast 2020-2027 (USD Million) 10.1. Pediatric 10.2. Adult 11. Global Influenza Vaccine Market, By Route of Administration Historical Analysis and Forecast 2020-2027 (USD Million) 11.1. Injection 11.2. Nasal Spray 12. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 12.2.1. U.S.A 12.2.2. Canada 12.2.3. Mexico 12.3. Market Size (USD Million) Forecast for North America 2020-2027 13. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 13.1. Introduction 13.2. Regional Market Trends 13.3. Historical Market Size (USD Million) Analysis By Country, 2015-2019 13.3.1. Brazil 13.3.2. Venezuela 13.3.3. Argentina 13.3.4. Rest of Latin America 13.4. Market Size (USD Million) Forecast for Latin America 2020-2027 14. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 14.2.1. Germany 14.2.2. U.K 14.2.3. France 14.2.4. Italy 14.2.5. Spain 14.2.6. Russia 14.2.7. Poland 14.2.8. Switzerland 14.2.9. Rest of Western Europe 15. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 15.2.1. Japan 15.2.2. China 15.2.3. Singapore 15.2.4. India 15.2.5. Australia and New Zealand 15.2.6. ASEAN 15.2.7. South Korea 15.2.8. Rest of Asia Pacific 15.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027 16. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 16.1. Introduction 16.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 16.2.1. Saudi Arabia 16.2.2. UAE 16.2.3. South Africa 16.2.4. Egypt 16.3. Market Size (USD Million) Forecast for MEA 2020-2027 17. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Technology Portfolio, Financial Layouts) 17.1. ASTRAZENECA PLC (ASTRAZENECA) 17.1.1. Company Overview 17.1.2. Product Portfolio 17.1.3. SWOT Analysis 17.1.4. Financial Overview 17.1.5. Strategic Overview 17.2. BIODIEM 17.2.1. Company Overview 17.2.2. Product Portfolio 17.2.3. SWOT Analysis 17.2.4. Financial Overview 17.2.5. Strategic Overview 17.3. CSL LIMITED (SEQIRUS GMBH) 17.3.1. Company Overview 17.3.2. Product Portfolio 17.3.3. SWOT Analysis 17.3.4. Financial Overview 17.3.5. Strategic Overview 17.4. EMERGENT BIOSOLUTIONS 17.4.1. Company Overview 17.4.2. Product Portfolio 17.4.3. SWOT Analysis 17.4.4. Financial Overview 17.4.5. Strategic Overview 17.5. F. HOFFMANN-LA ROCHE LTD. 17.5.1. Company Overview 17.5.2. Product Portfolio 17.5.3. SWOT Analysis 17.5.4. Financial Overview 17.5.5. Strategic Overview 17.6. GAMMA VACCINES PTY LTD. 17.6.1. Company Overview 17.6.2. Product Portfolio 17.6.3. SWOT Analysis 17.6.4. Financial Overview 17.6.5. Strategic Overview 17.7. GLAXOSMITHKLINE PLC 17.7.1. Company Overview 17.7.2. Product Portfolio 17.7.3. SWOT Analysis 17.7.4. Financial Overview 17.7.5. Strategic Overview 17.8. MERCK & CO. INC. (MERCK SHARP & DOHME CORP.) 17.8.1. Company Overview 17.8.2. Product Portfolio 17.8.3. SWOT Analysis 17.8.4. Financial Overview 17.8.5. Strategic Overview 17.9. NOVARTIS AG 17.9.1. Company Overview 17.9.2. Product Portfolio 17.9.3. SWOT Analysis 17.9.4. Financial Overview 17.9.5. Strategic Overview 17.10. PFIZER INC. 17.10.1. Company Overview 17.10.2. Product Portfolio 17.10.3. SWOT Analysis 17.10.4. Financial Overview 17.10.5. Strategic Overview 17.11. SANOFI 17.11.1. Company Overview 17.11.2. Product Portfolio 17.11.3. SWOT Analysis 17.11.4. Financial Overview 17.11.5. Strategic Overview 17.12. SINOVAC BIOTECH LTD. 17.12.1. Company Overview 17.12.2. Product Portfolio 17.12.3. SWOT Analysis 17.12.4. Financial Overview 17.12.5. Strategic Overview 18. FutureWise SME key takeaway points for Client
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders
2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data from Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data from Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study
3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights 4. Global Influenza Vaccine Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances
5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Influenza Vaccine Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Global Influenza Vaccine Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Global Influenza Vaccine Market, By Vaccine Type Historical Analysis and Forecast 2020-2027 (USD Million) 7.1. Quadrivalent 7.2. Trivalent
8. Global Influenza Vaccine Market, By Type Historical Analysis and Forecast 2020-2027 (USD Million) 8.1. Seasonal 8.2. Pandemic
9. Global Influenza Vaccine Market, By Technology Historical Analysis and Forecast 2020-2027 (USD Million) 9.1. Egg-based 9.2. Cell-based
10. Global Influenza Vaccine Market, By Age Group Historical Analysis and Forecast 2020-2027 (USD Million) 10.1. Pediatric 10.2. Adult
11. Global Influenza Vaccine Market, By Route of Administration Historical Analysis and Forecast 2020-2027 (USD Million) 11.1. Injection 11.2. Nasal Spray
12. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 12.2.1. U.S.A 12.2.2. Canada 12.2.3. Mexico 12.3. Market Size (USD Million) Forecast for North America 2020-2027
13. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 13.1. Introduction 13.2. Regional Market Trends 13.3. Historical Market Size (USD Million) Analysis By Country, 2015-2019 13.3.1. Brazil 13.3.2. Venezuela 13.3.3. Argentina 13.3.4. Rest of Latin America 13.4. Market Size (USD Million) Forecast for Latin America 2020-2027
14. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 14.2.1. Germany 14.2.2. U.K 14.2.3. France 14.2.4. Italy 14.2.5. Spain 14.2.6. Russia 14.2.7. Poland 14.2.8. Switzerland 14.2.9. Rest of Western Europe
15. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 15.2.1. Japan 15.2.2. China 15.2.3. Singapore 15.2.4. India 15.2.5. Australia and New Zealand 15.2.6. ASEAN 15.2.7. South Korea 15.2.8. Rest of Asia Pacific 15.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027
16. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 16.1. Introduction 16.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 16.2.1. Saudi Arabia 16.2.2. UAE 16.2.3. South Africa 16.2.4. Egypt 16.3. Market Size (USD Million) Forecast for MEA 2020-2027
17. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Technology Portfolio, Financial Layouts) 17.1. ASTRAZENECA PLC (ASTRAZENECA) 17.1.1. Company Overview 17.1.2. Product Portfolio 17.1.3. SWOT Analysis 17.1.4. Financial Overview 17.1.5. Strategic Overview 17.2. BIODIEM 17.2.1. Company Overview 17.2.2. Product Portfolio 17.2.3. SWOT Analysis 17.2.4. Financial Overview 17.2.5. Strategic Overview 17.3. CSL LIMITED (SEQIRUS GMBH) 17.3.1. Company Overview 17.3.2. Product Portfolio 17.3.3. SWOT Analysis 17.3.4. Financial Overview 17.3.5. Strategic Overview 17.4. EMERGENT BIOSOLUTIONS 17.4.1. Company Overview 17.4.2. Product Portfolio 17.4.3. SWOT Analysis 17.4.4. Financial Overview 17.4.5. Strategic Overview 17.5. F. HOFFMANN-LA ROCHE LTD. 17.5.1. Company Overview 17.5.2. Product Portfolio 17.5.3. SWOT Analysis 17.5.4. Financial Overview 17.5.5. Strategic Overview 17.6. GAMMA VACCINES PTY LTD. 17.6.1. Company Overview 17.6.2. Product Portfolio 17.6.3. SWOT Analysis 17.6.4. Financial Overview 17.6.5. Strategic Overview 17.7. GLAXOSMITHKLINE PLC 17.7.1. Company Overview 17.7.2. Product Portfolio 17.7.3. SWOT Analysis 17.7.4. Financial Overview 17.7.5. Strategic Overview 17.8. MERCK & CO. INC. (MERCK SHARP & DOHME CORP.) 17.8.1. Company Overview 17.8.2. Product Portfolio 17.8.3. SWOT Analysis 17.8.4. Financial Overview 17.8.5. Strategic Overview 17.9. NOVARTIS AG 17.9.1. Company Overview 17.9.2. Product Portfolio 17.9.3. SWOT Analysis 17.9.4. Financial Overview 17.9.5. Strategic Overview 17.10. PFIZER INC. 17.10.1. Company Overview 17.10.2. Product Portfolio 17.10.3. SWOT Analysis 17.10.4. Financial Overview 17.10.5. Strategic Overview 17.11. SANOFI 17.11.1. Company Overview 17.11.2. Product Portfolio 17.11.3. SWOT Analysis 17.11.4. Financial Overview 17.11.5. Strategic Overview 17.12. SINOVAC BIOTECH LTD. 17.12.1. Company Overview 17.12.2. Product Portfolio 17.12.3. SWOT Analysis 17.12.4. Financial Overview 17.12.5. Strategic Overview
18. FutureWise SME key takeaway points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics